Latest News and Press Releases

NEC X opens applications for Batch 14 of Elev X! Ignite, offering up to $250K and world-class support to entrepreneurs with bold, scalable tech ideas.

NEC Networks & System Integration Corporation (NESIC) selects the Cloudbrink SASE service as the foundation of its Virtual Trusted Overlay Network

As part of Cloudbrink's global expansion, they are pleased to announce signing up NEC Networks & System Integration Corporation for the Philippines.

Cloudbrink, has extended its partnership with NEC Networks & System Integration Corporation to the Philippines.

Antalet aktier och röster i Infant Bacterial Therapeutics AB (publ) har förändrats med anledning av den nyligen genomförda företrädesemissionen (för mer information, se bolagets pressmeddelande den 4...

The number of shares and votes in Infant Bacterial Therapeutics AB (publ) has changed due to the recently completed rights issue (for further information, see the company’s press release on 4 July...

EJ FÖR OFFENTLIGGÖRANDE, DISTRIBUTION ELLER PUBLICERING, HELT ELLER DELVIS, DIREKT ELLER INDIREKT, I ELLER TILL USA, AUSTRALIEN, KANADA, NYA ZEELAND, HONGKONG, JAPAN, SCHWEIZ, SINGAPORE, SYDAFRIKA,...

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, NEW ZEALAND, HONG KONG, JAPAN, SWITZERLAND,...

FDA har beviljat särläkemedelsstatus för IBT:s produkt IBP-1016 för gastroschisis.    Barn som drabbas av gastroschisis har ökade risker av tillväxthämning, sepsis och NEC vilket i sin tur...

The FDA has granted orphan drug designation for IBT’s product IBP-1016 for gastroschisis. Infants suffering from gastroschisis suffer from risks of growth retardation, sepsis and NEC which leads to...